在免疫逃避和免疫治疗中m6A修改的作用
Chunyu Wu1,2, Lvyuan Li2, Qiling Tang2
1NHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Medical oncology (Northwood, London, England)
|May 18, 2024
概括
在癌症的发展和免疫规避中,N6-甲基氨酸 (m6A) RNA 修饰至关重要. m6A的失调影响瘤生长,免疫细胞功能和瘤微环境,提供新的治疗点.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 免疫学 免疫学 免疫学
背景情况:
- 越来越多地认识到RNA修饰,特别是N6-甲基氨酸 (m6A),它们在癌症和免疫反应中的作用.
- m6A是最丰富的内部RNA修饰,通过甲基化腺残留物来调节基因表达.
- 异常的m6A水平与癌症进展,免疫细胞功能障碍以及免疫抑制瘤微环境 (TME) 的建立有关.
研究的目的:
- 审查关于m6A在瘤和免疫细胞中的失调如何导致免疫逃避的最新发现.
- 探索瘤细胞中的m6A修饰对TME内的免疫细胞的影响.
- 讨论针对癌症免疫治疗的m6A途径的新兴治疗策略.
主要方法:
- 在癌症和免疫学中对m6A修饰的最新研究的文献综述.
- 对参与m6A介导免疫逃避的信号通路的分析.
- 检查m6A调节器和基于纳米材料的疗法.
主要成果:
- 瘤和免疫细胞中的m6A异常激活了促进免疫逃避的信号通路.
- 瘤细胞中失调的m6A改变了免疫细胞的功能和TME内的相互作用,促进了瘤的生长.
- 特定的m6A调节剂抑制剂和m6A向纳米材料在癌症治疗方面显示出有前途.
结论:
- m6A修饰在通过TME内的复杂相互作用来协调瘤免疫逃避中发挥着关键作用.
- 准m6A通路为开发新型癌症免疫疗法提供了一个有希望的途径.
- 对m6A调节器和纳米材料传递系统的进一步研究有必要进行临床转化.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Mismatch Repair
4.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Tumor Immunotherapy
515
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
515
Cytotoxic T Cells-mediated Immune Response
892
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
892


